RT Journal Article
SR Electronic
T1 Deep learning-based prognosis models accurately predict the time to delivery among preeclampsia patients using health records at the time of diagnosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.03.22273366
DO 10.1101/2022.04.03.22273366
A1 Yang, Xiaotong
A1 Ballard, Hailey K
A1 Mahadevan, Aditya D
A1 Xu, Ke
A1 Garmire, David G
A1 Langen, Elizabeth S
A1 Lemas, Dominick J
A1 Garmire, Lana X
YR 2024
UL http://medrxiv.org/content/early/2024/08/09/2022.04.03.22273366.abstract
AB Background Preeclampsia (PE) is one of the leading factors in maternal and perinatal mortality and morbidity worldwide with no known cure. Delivery timing is key to balancing maternal and fetal risk in pregnancies complicated by PE. Delivery timing of PE patients is traditionally determined by closely monitoring over a prolonged time. We developed and externally validated a deep learning models that can predict the time to delivery of PE patients, based on electronic health records (EHR) data by the time of the initial diagnosis, in the hope of reducing the need for close monitoring.Method Using the deep-learning survival model (Cox-nnet), we constructed time-to-delivery prediction models for all PE patients and early-onset preeclampsia (EOPE) patients. The discovery cohort consisted of 1,533 PE cases, including 374 EOPE, that were delivered at the University of Michigan Health System (UM) between 2015 and 2021. The validation cohort contained 2,172 PE cases (547 EOPE) from the University of Florida Health System (UF) in the same time period. We built clinically informative baseline models from 45 pre-diagnosis clinical variables that include demographics, medical history, comorbidity, PE severity, and initial diagnosis gestational age features. We also built full models from 60 clinical variables that include additional 15 lab tests and vital signs features around the time of diagnosis.Results The 7-feature baseline models on all PE patients reached C-indices of 0.74 and 0.73 on UM hold-out testing and UF validation dataset respectively, whereas the 12-feature full model had improved C-indices of 0.79 and 0.74 on the same datasets. For the more urgent EOPE cases, the 6-feature baseline model achieved C-indices of 0.68 and 0.63, and its 13-feature full model counterpart reached C-indices of 0.76 and 0.67 in the same datasets.Conclusions We successfully developed and externally validated an accurate deep-learning model for time-to-delivery prediction among PE patients at the time of diagnosis, which helps to prepare clinicians and patients for expected deliveries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementLXG was supported by grants R01 LM012373 and LM012907 awarded by NLM, R01 HD084633 awarded by NICHD. DJL was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK115632) and the University of Florida Clinical and Translational Science Institute (UL1TR001427). XY is supported by NIH/NIGMS Grant T32GM141746. AM is supported by the National Center for Advancing Translational Science (5TL1TR001428).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the University of Michigan Medical School gave ethical approval for this work(HUM#00168171).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPEpreeclampsiasPEPreeclampsia with severe featuresEOPEearly-onset preeclampsiaLOPElate-onset preeclampsiaEHRelectronic health recordSBPsystolic blood pressureDBPdiastolic blood pressureRRrespiratory rateHELLPhemolysis, elevated liver enzymes, low platelet countASTaspartate transaminasePIprognosis scoreUMUniversity of MichiganUFUniversity of FloridaICD-10The International Classification of Diseases, Tenth RevisionMAPmean arterial pressureUtA-PIuterine artery pulsatility indexPLGFplacental growth factorACOGAmerican College of Obstetricians and GynecologistAUROCArea Under the Receiver-Operator curve